enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Guardant's blood-based cancer test moves closer to Medicare ...

   www.aol.com/news/us-fda-approves-guardant-health...

   Blood-based tests are also more convenient than feces-based tests, such as Exact Sciences' Cologuard, for cancer screening. According to the FDA's documents, a study showed Guardant's Shield test ...

3. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   On July 29, 2024, the Food and Drug Administration (FDA) approved a blood test that can help with primary colorectal cancer screening. The test is Guardant Health’s Shield blood test, and the ...

4. Blood test to detect colon cancer could move a step closer to ...

   www.aol.com/news/blood-test-detect-colon-cancer...

   Current options for colorectal cancer screening for people at average risk include a stool-based test done either annually or every three years; a traditional colonoscopy every 10 years; a virtual ...

5. Blood test for colon cancer screening is approved by US ...

   lite.aol.com/news/world/story/0001/20240729/a2c2...

   Physicians will be able to run the Shield test after taking a simple blood draw, Guardant said in a statement. The company plans to launch its product “in the near future.” The annual rate of U.S. colon cancer screening is nearly 60%, well short of the 80% of age-eligible adults goal set by the American Cancer Society and other groups. ___

6. Stool guaiac test - Wikipedia

   en.wikipedia.org/wiki/Stool_guaiac_test

   Several recent colon cancer screening guidelines have recommended replacing any older low-sensitivity, guaiac-based fecal occult blood testing (gFOBT) with either newer high-sensitivity guaiac-based fecal occult blood testing (gFOBT) or fecal immunochemical testing (FIT), which tests for globin rather than the heme detected by the guaiac method.

7. Guardant Health - Wikipedia

   en.wikipedia.org/wiki/Guardant_Health

   Guardant Health also launched a colon cancer detection test called Shield. [43] The company partnered with the Vall d'Hebron Institute of Oncology to launch the first blood-based cancer testing services in Barcelona in mid 2022. [44] Guardant Health also licensed cancer tests to the clinical laboratory company Adicon for research testing in China.